SEC filings and other documents

Record Q2 revenue, strong institutional growth, and new product launches drive momentum.

Director election amendments failed; all nominated directors reelected; no shareholder questions.

CFTC's Bitcoin perpetual approval sparks risk warnings amid new product launches and efficiency focus.

Record Q1 2026 with all-time highs in volume, revenue, and net income, plus major product innovation.

Global growth, product innovation, and high margins drive record performance and shareholder returns.

Record 2025 growth fueled by innovation, global reach, and strong capital efficiencies.

Record revenues, volumes, and innovation in 2025 set the stage for strong 2026 growth.

Record crypto and market data volumes offset lower revenue, with robust margins and innovation.

Record Q2 with double-digit growth in volume, revenue, and earnings, led by global and retail demand.

Record volumes, global growth, and retail innovation drive a dynamic, risk-focused outlook.

Record financials, all proposals approved, and strong outlook amid competition and litigation.

Record revenue, net income, and volumes driven by global demand and product innovation.

International growth, product innovation, and margin efficiencies drive record performance.

S&P 500 ESG Index rebranded as Scores and Screens, fueling growth in liquid ESG investment products.

Record 2024 revenues and volumes fueled CME Group's earnings growth and global expansion.